Overview

Losartan and Social Processing

Status:
RECRUITING
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
This study explores the effects of single-dose losartan (50mg) versus placebo on social processing in healthy volunteers.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
University of Oxford
Collaborator:
Oxford Health Biomedical Research Centre (OH BRC) support scheme
Treatments:
Losartan